The Non-Malignant Channel on VJHemOnc is an independent medical education platform, supported with funding from Agios (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Thalassemia Channel on VJHemOnc is an independent medical education platform, supported with funding from Agios (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ASCAT 2023 | Bone Marrow Quality Index to assess the safety of HSCT in thalassemia
Lawrence Faulkner, MD, Cure2Children Foundation, Florence, Italy, discusses his recent publication on the use of a bone marrow quality index to predict graft-versus-host disease (GvHD) in hematopoietic stem cell transplantation (HSCT) for thalassemia. This interview was held at the 18th Annual Scientific Conference on Sickle Cell and Thalassemia (ASCAT) 2023, held in London, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
